70 engineering-engineering "https:" "https:" "https:" "https:" "Computer Vision Center" Postdoctoral positions in Switzerland
Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
, diabetes and cancer; see https://data.snf.ch/grants/grant/189065 ii) developing and validation of novel chemical probes and degraders to dissect mechanisms of adverse effects in cancer and metabolism. For a
-
universities specialising in science and technology. We are renowned for our excellent education, cutting-edge fundamental research and direct transfer of new knowledge into society. Over 30,000 people from
-
EPFL, the Swiss Federal Institute of Technology in Lausanne, is one of the most dynamic university campuses in Europe and ranks among the top 20 universities worldwide. The EPFL employs more than
-
are therefore strongly encouraged. About ETH ZürichETH Zurich is one of the world’s leading universities specialising in science and technology. We are renowned for our excellent education, cutting-edge
-
of phosphoinositide 3-kinase (PI3K) signaling in allergy, metabolic control, obesity, diabetes and cancer; see https://p3.snf.ch/project-189065 ii) developing and validation of novel chemical probes and degraders
-
EPFL, the Swiss Federal Institute of Technology in Lausanne, is one of the most dynamic university campuses in Europe and ranks among the top 20 universities worldwide. The EPFL employs more than
-
your application before July 31, 2026. However, there is no deadline for applying, and the position will be open until a suitable candidate is found. Where to apply Website https://academicpositions.com
-
EPFL, the Swiss Federal Institute of Technology in Lausanne, is one of the most dynamic university campuses in Europe and ranks among the top 20 universities worldwide. The EPFL employs more than
-
information can be found on our website (https://www.epfl.ch/campus/services/human-resources/en/basic-starting-salary-of-doctoral-assistants-and-postdocs/) Opportunity to perform state-of-the-art research in
-
anatomy of the central nervous system. The current line of enquiry is to engineer human B cells to express a B cell receptor of interest in a way that enables native-like class switch, somatic hypermutation